DLT Resolution (DLTI) 10-K 23 May 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	May. 23, 2016
Document And Entity Information
Entity Registrant Name	HEMCARE HEALTH SERVICES INC.
Entity Central Index Key	1,420,368
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	Yes
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Entity Public Float		$ 0
Entity Common Stock, Shares Outstanding		141,782,211
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash	$ 20,334
Prepaid expenses	2,630
Total current assets	22,964
Total assets	22,964	$ 0
Current liabilities
Accounts payable and accrued liabilities	86,896	$ 67,665
Dividends payable	19,000
Related party payables	37,249	$ 37,249
Current notes payables	350,000
Related party convertible notes payable, net of discounts $10,249 and $0	385
Convertible notes payable, net of discounts $12,835 and $0	3,865
Total current liabilities	497,395	$ 104,914
Stockholders' deficit
Common stock, $0.001 par value; 275,000,000 shares authorized; 142,162,211 and 3,136,000 issued; 141,782,211 and 2,756,000 outstanding at December 31, 2015 and 2014	142,162	3,136
Additional paid in capital	2,556,665	2,377,270
Other comprehensive income	24	24
Treasury stock, 380,000 shares	(100)	(100)
Accumulated deficit	(3,254,352)	(2,605,244)
Total stockholders' deficit	(474,431)	(104,914)
Total liabilities and stockholders' deficit	22,964	0
Series A convertible preferred Stock [Member]
Stockholders' deficit
Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized, 81,170 and 120,000 and shares issued and outstanding at December 31, 2015 and 2014	$ 81,170	$ 120,000

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current liabilities
Convertible notes payable, net of discounts	$ 10,249	$ 0
Convertible notes payable, net of discounts	$ 12,835	$ 0
Stockholders' deficit
Convertible preferred stock; par value	$ 1	$ 1
Common stock; par value	$ 0.001	$ 0.001
Common stock; shares authorized	275,000,000	275,000,000
Common stock; shares issued	142,162,211	3,136,000
Common stock; shares outstanding	141,782,211	2,756,000
Treasury stock shares	380,000	380,000
Series A convertible preferred Stock [Member]
Stockholders' deficit
Convertible preferred stock; par value	$ 1	$ 1
Convertible preferred stock; shares authorized	5,000,000	5,000,000
Convertible preferred stock; shares issued	81,170	120,000
Convertible preferred stock; shares outstanding	81,170	120,000

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Statements Of Operations
Revenue
Operating expenses
General and administrative	$ 23,977
Professional fees	375,284	$ 26,340
Total operating expenses	399,261	26,340
Other income (expense)
Other income	937	$ 100
Interest expense	(32,177)
Excess cost of prepaid royalties over value	(199,607)	$ (160,105)
Total other income (expense)	(230,847)	(160,005)
Net loss	(630,108)	$ (186,345)
Preferred stock dividends payable	(19,000)
Net loss attributable to common shareholders	$ (649,108)	$ (186,345)
Basic and diluted loss per common share	$ (0.01)	$ (0.06)
Weighted average shares outstanding	87,783,992	2,932,578

Statement of Changes in Stockho

Statement of Changes in Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Other Comprehensive Income	Treasury Stock	Accumulated Deficit	Total
Beginning Balance, Shares at Dec. 31, 2013		3,136,000
Beginning Balance, Amount at Dec. 31, 2013		$ 3,136	$ 2,337,165	$ 24		$ (2,418,899)	$ (78,574)
Preferred shares issued for prepayment of royalty, Shares	120,000
Preferred shares issued for prepayment of royalty, Amount	$ 120,000		$ 40,105				160,105
Treasury stock exchanged for asset, Shares		(380,000)
Treasury stock exchanged for asset, Amount					$ (100)		$ (100)
Dividend declared on preferred stock
Net loss						$ (186,345)	$ (186,345)
Ending Balance, Shares at Dec. 31, 2014	120,000	2,756,000
Ending Balance, Amount at Dec. 31, 2014	$ 120,000	$ 3,136	$ 2,377,270	$ 24	$ (100)	$ (2,605,244)	(104,914)
Preferred shares issued for prepayment of royalty, Shares	100,000
Preferred shares issued for prepayment of royalty, Amount	$ 100,000		$ 99,607				$ 199,607
Conversion of preferred shares to common shares, Shares	(138,830)	138,830,000
Conversion of preferred shares to common shares, Amount	$ (138,830)	$ 138,830
Issuance of common shares for rounding in stock split, Shares		26,211
Issuance of common shares for rounding in stock split, Amount		$ 26	$ (26)
Recession of common shares, Shares		(730,000)
Recession of common shares, Amount		$ (730)	730
Common stock issued for cash, Shares		900,000
Common stock issued for cash, Amount		$ 900	44,100				$ 45,000
Beneficial conversion features recorded as debt discounts			$ 34,984				34,984
Dividend declared on preferred stock						$ (19,000)	(19,000)
Net loss						(630,108)	(630,108)
Ending Balance, Shares at Dec. 31, 2015	81,170	141,782,211
Ending Balance, Amount at Dec. 31, 2015	$ 81,170	$ 142,162	$ 2,556,665	$ 24	$ (100)	$ (3,254,352)	$ (474,431)

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net loss from operations	$ (630,108)	$ (186,345)
Adjustments to reconcile net loss to net cash used in operating activities
Excess cost of prepaid royalties over value	$ 199,607	160,105
Gain on sale of intangible asset for treasury stock		$ (100)
Note payable entered into for professional fees	$ 350,000
Amortization of debt discounts	11,900
Expenses paid on behalf of company by related parties	15,784	$ 18,035
Changes in operating assets and liabilities
Prepaid expenses	(2,630)	800
Accounts payable and accrued liabilities	19,231	$ 7,505
Net cash provided by (used in) operating activities	$ (36,216)
Net cash used in investing activities
Cash flows from financing activities
Proceeds from convertible notes payable	$ 19,700
Repayments of convertible notes payable	(3,000)
Repayments of related party convertible notes payable	(5,150)
Proceeds from sale of common stock	45,000
Net cash provided by financing activities	56,550
Net change in cash	$ 20,334
Cash at beginning of period
Cash at end of period	$ 20,334
Supplemental cash flow information
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities
Preferred stock issued for prepaid royalties	$ 100,000	$ 120,000
Related party convertible notes entered into in exchange for related party payable	15,784
Note payable entered into for professional fees	$ 350,000

Nature of Business

Nature of Business	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 1 - Nature of Business	The Company was organized January 17, 2007 (Date of Inception) under the laws of the State of Nevada, as DBL Senior Care, Inc. The Company subsequently changed its name on December 11, 2009 to Elemental Protective Coatings Corp, subsequently changed its name on January 27, 2011 to Bio-Carbon Solutions International, Inc., then to NSU Resources Inc on October 31, 2011 and more recently to HemCare Health Services Inc. on March 2, 2015. The Company produces and distributes a line of all-in-one horse feed supplement. The former business of the Company was to provide personal care services to elderly, physically disabled or other home-bound individuals suffering infirmity. During the year ended December 31, 2009, the board of directors changed the Company's focus toward the manufacture and sale of fire retardant products. The Company then changed its focus to the licensing of certain technologies related to rare earth minerals mining then to having the exclusive rights to the use of Optimum Performance (a proprietary formulation of a highly potent all-in-one daily feed supplement for the Horse industry. Currently, the Company has shifted its focus to hemorrhoid medical procedures and entered into a license agreement to open hemorrhoid treatment centers and promote the Ultroid Hemorrhoid System globally

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 2 - Significant Accounting Policies	Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2015 or 2014. Income taxes Income taxes are provided for using the liability method of accounting in accordance with FASB ASC Topic 740 (formally SFAS No. 109 "Accounting for Income Taxes"). A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment. Revenue Recognition Revenue is recognized when persuasive evidence of an agreement exists, the price is fixed or determinable, goods are delivered or services performed and collectability is reasonably assured. The Company did not generate any revenues during the years ended December 31, 2015 or 2014. Convertible debt The Company records a beneficial conversion feature related to the issuance of convertible debts that have conversion features at fixed or adjustable rates. The beneficial conversion feature for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features. The beneficial conversion feature will be accreted by recording additional non-cash interest expense over the expected life of the convertible notes. Share Based Expenses The Company complies with FASB ASC Topic 718 Compensation—Stock Compensation, which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that is based on the fair value of the entity's equity instruments or that may be settled by the issuance of those equity instruments. FASB ASC Topic 718 primarily focuses on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This statement requires a public entity to expense the cost of employee services received in exchange for an award of equity instruments. This statement also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted FASB ASC Topic 718 upon formation of the Company and expenses share based costs in the period incurred. Going concern The Company's financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. Currently, the Company has no cash, no material assets, accumulated losses of $3,428,812, a working capital deficit of $118,891, nor does it have operations or a source of revenue sufficient to cover its operation costs and allow it to continue as a going concern. The Company will be dependent upon the raising of additional capital through placement of our common stock in order to implement its business plan, or merge with an operating company. There can be no assurance that the Company will be successful in either situation in order to continue as a going concern. The officers and directors have committed to advancing certain operating costs of the Company. Valuation of Investments in Securities and Securities at fair value – Definition and Hierarchy FASB ASC 820-10-15 defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. FASB ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows: Level 1 – unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company at the measurement date. Level 2 – inputs that are observable in the marketplace other than those inputs classified as Level 1. Level 3 – inputs that are unobservable in the marketplace and significant to the valuation. The Company has no assets or liabilities that are required to be carried at fair value. Accounts payable and related party payables have fair values that approximate the carrying value due to the short term nature of these instruments. Recent Accounting Pronouncements Recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not, or are not believed by management to, have a material impact on the Company's present or future consolidated financial statements. Net loss per common share Net loss per share is calculated in accordance with FASB ASC Topic 260 (formerly SFAS No. 128, Earnings Per Share). The weighted-average number of common shares outstanding during each period is used to compute basic loss per share. Diluted loss per share is computed using the weighted average number of shares and dilutive potential common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised. Basic net loss per common share is based on the weighted average number of shares of common stock outstanding during the periods presented. The Company had 84,668,400 common stock equivalents that were excluded from earnings per share due to the anti-dilutive nature.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 3 - Stockholders' Equity	Series A Convertible Preferred Stock As discussed in the 8K filed with the SEC on June 29, 2014, during the year ended December 31, 2014, the Company amended its articles of incorporation to designate the previously authorized series A preferred stock to series A convertible preferred stock. The preferred series A 12% convertible shares have a par value of $1, entitle holder to one vote and accrue dividends at 12% per year, paid quarterly. At the option of the holder, the stock can be converted into shares of the Company's common stock. The number of shares to be issued will be determined by dividing the amount of the Series A shares being converted by $0.001. During the year ended December 31, 2014, the Company issued 120,000 shares of series A convertible preferred stock in exchange for a prepayment of royalties to a related party totaling $120,000. During year ended December 31, 2015, the Company issued 100,000 shares of series A convertible preferred stock in exchange for a prepayment of royalties with a deemed value of $0 due to the undeterminable nature of the true future usable value to the Company. The Company also accepted the conversion notices from certain series A convertible preferred shareholders to convert a total of 138,830 shares of series A preferred stock to 138,830,000 shares of $0.001 par value common stock. The excess of the value of the preferred shares issued in excess of the value of the prepaid royalties has been expensed as a financing cost. There were 81,170 and 120,000 shares of series A convertible preferred stock issued and outstanding as of December 31, 2015 and 2014. Additionally, the Company had accrued dividends payable on series A convertible preferred stock totaling $19,000 and $0 at December 31, 2015 and 2014. Common Stock On March 2, 2015, the Company effected a 1:50 reverse stock split. The effects of the reverse split are shown retroactively in these financial statements. The authorized common stock of the Company consists of 275,000,000 shares and carries a par value of $0.001. During the year ended December 31, 2014, the Company bought back 380,000 post-split shares of common stock into treasury from a former officer for $100. The shares are being carried as treasury shares as reflected on the balance sheet. During the year ended December 31, 2015, the Company rescinded 730,000 common shares previously issued pursuant to certain agreements. The Company determined the holders did not have legal right to the shares as issued. During the year ended December 31, 2015, the Company issued 138,830,000 common shares from the conversion of 138,830 shares of Series A Preferred Stock. During the year ended December 31, 2015, the Company issued 900,000 shares of common stock for total cash proceeds of $45,000 and 26,211 shares to account for rounding in our 1:50 stock split as previously discussed. There were 142,162,211 and 3,136,000 common shares issued and 141,782,211 and 2,756,000 outstanding (post-split) at December 31, 2015 and 2014, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 4 - Income Taxes	We did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because we have experienced operating losses since inception. Pursuant to FASB ASC Topic 740, when it is more likely than not that a tax asset cannot be realized through future income, the Company must provide an allowance for this future tax benefit. We provided a full valuation allowance on the net deferred tax asset, consisting of net operating loss carry-forwards, because management has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during the carry-forward period. The sources and tax effects of the temporary differences for the periods presented are as follows: December 31, 2015 December 31, 2014 Net operating loss carry forward $ 748,640 $ 318,139 Applicable Canadian Federal and Provincial tax rates 26.5 % 26.5 % Deferred tax asset 198,390 84,307 Valuation allowance (198,390 ) (84,307 ) Net deferred tax asset $ - $ - This represents an increase in the net operating loss carry forward of $430,501 and $19,869 for the years ended December 31, 2015 and 2014. A reconciliation of income taxes computed at the United States federal statutory rate of 35% to the income tax recorded is as follows: December 31, 2015 December 31, 2014 Tax benefit at United States Federal statutory rate (35%) $ 220,538 $ 65,221 Differences in U.S. and Canadian tax rates on provision (36,592 ) (15,839 ) Non-deductible losses-prepaids (69,862 ) (42,428 ) Increase in valuation allowance (114,083 ) (6,954 ) Income tax provision $ - $ - This represents an increase in the valuation allowance of $114,083 and $6,954 for the years ended December 31, 2015 and 2014. The Company did not pay any income taxes during the years ended December 31, 2015 or 2014, or since inception. The net federal operating loss carry forward will begin to expire in 2026. This carry forward may be limited upon the consummation of a business combination under IRC Section 381. Tax years commencing in 2012 remain open for examination by the IRS, where applicable.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 5 - Related Party Transactions	During the years ended December 31, 2015 and 2014, the Company received loans from its officers totaling $15,784 and $18,035 to fund operations via expenses paid directly to vendors on behalf of the Company. These loans are non-interest bearing, are due on demand and as such included in current liabilities. Imputed interest has been considered, but determined to be immaterial to the financial statements as a whole. On August 8, 2015, the Company entered into a convertible note payable for $15,784 in exchange for the related party payable incurred from expenses paid on behalf of the Company. The note carries interest at a rate of 6% per annum, is due on August 24, 2016 and may be converted into common stock of the Company at the option of the noteholder at a rate of $.01 per share. The beneficial conversion feature in the note created a debt discount of $15,784 of which $5,535 was recognized during the year ended December 31, 2015 leaving an unamortized discount of $10,249 as of December 31, 2015 that will be recognized over the remaining life of the note. There was $10,634 of interest plus accrued interest totaling $360 due as of December 31, 2015.

Excess Cost of Prepaid Royaltie

Excess Cost of Prepaid Royalties Over Value	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 6 - Excess Cost of Prepaid Royalties Over Value	During the year ended December 31, 2014, the Company issued a total of 120,000 preferred shares of $1 par value Series A convertible preferred stock. The shares carried a value of $160,105 resulting in an immediate excess payment over value of $160,105 based on the Company's determination that it may not realize value for the prepayment resulting in a full charge-off to operations for $160,105. During the year ended December 31, 2015, the Company issued a total of 100,000 preferred shares of $1 par value Series A convertible preferred stock. The shares carried a value of $199,607 resulting in an immediate excess payment over value of $199,607 based on the Company's determination that it may not realize value for the prepayment resulting in a full charge-off to operations for $199,607.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 7 - Notes Payable	During the year ended December 31, 2015, the Company entered into a note payable with an unrelated party as a settlement for payment of consulting services provided valued at $350,000. The note carries interest of 9% compounded annually and is due on November 19, 2016. There was $350,000 of principal and $19,504 of accrued interest due as of December 31, 2015. Accrued interest payable is included in "accounts payable and accrued liabilities" on the balance sheet.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 8 - Convertible Notes Payable	During the year ended December 31, 2015, the Company entered into a convertible note payable with an unrelated party resulting in net cash proceeds to the Company totaling $19,700. The note is convertible into common stock of the Company at the option of the noteholder at a rate of $0.01 per share. The Company measured the value of the beneficial conversion feature of the note and recorded a discount equal to the face value of the note on the date of issuance. The discount will be recognized ratably over the life of the note through the due date as shown below. A summary of the outstanding convertible note payable as of December 31, 2015 follows: Due Date Principal Discount Net Value Noteholder 1 9/1/2016 $ 16,700 $ (12,835 ) $ 3,865 Total $ 16,700 $ (12,835 ) $ 3,865

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Note 9 - Subsequent Events	We have evaluated subsequent events through the date of this filing and determined there are no additional events to disclose.

Significant Accounting Polici16

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Significant Accounting Policies Policies
Estimates	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash	For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2015 or 2014.
Income taxes	Income taxes are provided for using the liability method of accounting in accordance with FASB ASC Topic 740 (formally SFAS No. 109 "Accounting for Income Taxes"). A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.
Revenue Recognition	Revenue is recognized when persuasive evidence of an agreement exists, the price is fixed or determinable, goods are delivered or services performed and collectability is reasonably assured. The Company did not generate any revenues during the years ended December 31, 2015 or 2014.
Convertible debt	The Company records a beneficial conversion feature related to the issuance of convertible debts that have conversion features at fixed or adjustable rates. The beneficial conversion feature for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features. The beneficial conversion feature will be accreted by recording additional non-cash interest expense over the expected life of the convertible notes.
Share Based Expenses	The Company complies with FASB ASC Topic 718 Compensation—Stock Compensation, which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that is based on the fair value of the entity's equity instruments or that may be settled by the issuance of those equity instruments. FASB ASC Topic 718 primarily focuses on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This statement requires a public entity to expense the cost of employee services received in exchange for an award of equity instruments. This statement also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted FASB ASC Topic 718 upon formation of the Company and expenses share based costs in the period incurred.
Going concern	The Company's financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. Currently, the Company has no cash, no material assets, accumulated losses of $3,428,812, a working capital deficit of $118,891, nor does it have operations or a source of revenue sufficient to cover its operation costs and allow it to continue as a going concern. The Company will be dependent upon the raising of additional capital through placement of our common stock in order to implement its business plan, or merge with an operating company. There can be no assurance that the Company will be successful in either situation in order to continue as a going concern. The officers and directors have committed to advancing certain operating costs of the Company.
Valuation of Investments in Securities and Securities at fair value – Definition and Hierarchy	FASB ASC 820-10-15 defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. FASB ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows: Level 1 – unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company at the measurement date. Level 2 – inputs that are observable in the marketplace other than those inputs classified as Level 1. Level 3 – inputs that are unobservable in the marketplace and significant to the valuation. The Company has no assets or liabilities that are required to be carried at fair value. Accounts payable and related party payables have fair values that approximate the carrying value due to the short term nature of these instruments.
Recent Accounting Pronouncements	Recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not, or are not believed by management to, have a material impact on the Company's present or future consolidated financial statements.
Net loss per common share	Net loss per share is calculated in accordance with FASB ASC Topic 260 (formerly SFAS No. 128, Earnings Per Share). The weighted-average number of common shares outstanding during each period is used to compute basic loss per share. Diluted loss per share is computed using the weighted average number of shares and dilutive potential common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised. Basic net loss per common share is based on the weighted average number of shares of common stock outstanding during the periods presented. The Company had 84,668,400 common stock equivalents that were excluded from earnings per share due to the anti-dilutive nature.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Taxes Tables
Schedule of deferred income tax assets	December 31, 2015 December 31, 2014 Net operating loss carry forward $ 748,640 $ 318,139 Applicable Canadian Federal and Provincial tax rates 26.5 % 26.5 % Deferred tax asset 198,390 84,307 Valuation allowance (198,390 ) (84,307 ) Net deferred tax asset $ - $ -
Schedule of income Taxes	December 31, 2015 December 31, 2014 Tax benefit at United States Federal statutory rate (35%) $ 220,538 $ 65,221 Differences in U.S. and Canadian tax rates on provision (36,592 ) (15,839 ) Non-deductible losses-prepaids (69,862 ) (42,428 ) Increase in valuation allowance (114,083 ) (6,954 ) Income tax provision $ - $ -

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2015
Convertible Notes Payable Tables
Summary of the outstanding convertible notes payable	Due Date Principal Discount Net Value Noteholder 1 9/1/2016 $ 16,700 $ (12,835 ) $ 3,865 Total $ 16,700 $ (12,835 ) $ 3,865

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Dividends payable	$ 19,000
Conversion of preferred shares to common shares, Amount
Common stock issued for cash, Amount	$ 45,000
Common stock; shares authorized	275,000,000	275,000,000
Common stock; shares issued	142,162,211	3,136,000
Common stock; shares outstanding	141,782,211	2,756,000
Common Stock
Recession of common shares	(730,000)
Conversion of preferred shares to common shares, Amount	$ 138,830
Issuance of common shares for rounding in stock split, Shares	26,211
Common stock issued for cash, Amount	$ 900
Common stock issued for cash, Shares	900,000
Series A convertible preferred Stock [Member]
Repayment of royalty to related party	$ 100,000	$ 120,000
Repayment of royalty to related party value	$ 0	$ 120,000
Series A convertible preferred stock; shares issued	81,170	120,000
Series A convertible preferred stock; shares outstanding	81,170	120,000
Conversion of preferred shares to common shares	138,830,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Income Taxes Details
Net operating loss carry forward	$ 748,640	$ 318,139
Applicable Canadian Federal and Provincial tax rates	26.50%	26.50%
Deferred tax asset	$ 198,390	$ 84,307
Valuation allowance	$ (198,390)	$ (84,307)
Net deferred tax asset

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes Details 1
Tax benefit at United States Federal statutory rate (35%)	$ 220,538	$ 65,221
Differences in U.S. and Canadian tax rates on provision	(36,592)	(15,839)
Non-deductible losses-prepaids	(69,862)	(42,428)
Increase in valuation allowance	$ (114,083)	$ (6,954)
Income tax provision

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes Details Narrative
Net operating loss carryforwards	$ 430,501	$ 19,869
United States federal statutory rate	35.00%
Net operating loss carryforwards, expiration date	2,026
Valuation allowance	$ 114,083	$ 6,954

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Related Party Transactions Details Narrative
Unamortized discount	$ 10,249	$ 0
Accrued interest	10,634
Proceeds from related party loans	5,535
Related party payables	360
Expenses paid on behalf of company by related parties	$ 15,784	$ 18,035

Excess Cost of Prepaid Royalt24

Excess Cost of Prepaid Royalties Over Value (Details Narrative) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Series A convertible preferred stock; par value	$ 1	$ 1
Series A convertible preferred Stock [Member]
Series A convertible preferred stock; par value	$ 1	$ 1
Share issued	100,000

Notes Payable (Details Narrativ

Notes Payable (Details Narrative)	12 Months Ended
	Dec. 31, 2015USD ($)
Notes Payable Details Narrative
Note payable entered into for professional fees	$ 350,000
Accrued interest	$ 19,504

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Principal	$ 16,700
Discount	(12,835)
Net Value	$ 3,865
Noteholder 1 [Member]
Due Date	9/1/2016
Principal	$ 16,700
Discount	(12,835)
Net Value	$ 3,865

Convertible Notes Payable (De27

Convertible Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Convertible Notes Payable Details Narrative
Proceeds from convertible notes payable	$ 19,700